SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-19-040422
Filing Date
2019-07-15
Accepted
2019-07-15 21:35:54
Documents
1
Period of Report
2019-07-10

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3017
  Complete submission text file 0001104659-19-040422.txt   4539
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALPHASIMPLEX GROUP, LLC ONE CAMBRIDGE CENTER, 9TH FLOOR CAMBRIDGE MA 02142
Business Address
Lo Andrew (Reporting) CIK: 0001679076 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34949 | Film No.: 19956128